eWEAR Annual Meeting Symposium 2024

Bao is K.K. Lee Professor of Chemical Engineering, and by courtesy, a Professor of Chemistry and a Professor of Material Science and Engineering at Stanford University. Bao directs the Stanford Wearable Electronics Initiate (eWEAR) and the Taiwan Science and Technology Hub @ Stanford. She is a CZ Biohub investigator since 2022 and an Arc Institute Innovation Investigator since 2023.

Prior to joining Stanford in 2004, she was a Distinguished Member of Technical Staff in Bell Labs, Lucent Technologies from 1995-2004. She received her Ph.D in Chemistry from the University of Chicago in 1995.  She has more than 700 refereed publications and over 80 US patents with a Google Scholar H-Index 206 and is one of the world’s most highly cited scholars in the fields of chemistry and material science. She is one of the Clarivate Citation Laureates in Chemistry for her pioneering work on skin-inspired electronics.

Bao is a member of the National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. She a foreign member of the Chinese Academy of Science. She has been serving on the Board of Directors of the Camille and Henry Dreyfus Foundation and scientific affair committee from 2022. She is an advisor for the Science for America, a solutions incubator to address urgent challenges, driven by an unprecedented alliance of leading philanthropic organizations.

Bao is a recipient of the VinFuture Prize Female Innovator 2022, the ACS Chemistry of Materials Award 2022, MRS Mid-Career Award in 2021, AICHE Alpha Chi Sigma Award 2021, ACS Central Science Disruptor and Innovator Prize in 2020, Gibbs Medal 2020, Wilhelm Exner Medal2018, ACS Award on Applied Polymer Science 2017, L’Oréal-UNESCO For Women in Science Award 2017.

Bao is a co-founder and on the Board of Directors for C3 Nano and PyrAmes, both are silicon-valley venture funded start-ups. Research inventions from her group have been licensed and are foundational technologies of multiple start-ups founded by her students. Bao serves as an advisor for Fusion Venture and Boutique Venture.

In this talk, I will present our recent developments and applications of soft electronic sensors for neurochemicals, single neuron electrical recording and electrical stimulation.

Dr. Shinozaki is an Associate Professor of Psychiatry at Stanford University. Completed psychiatry residency and psychosomatic medicine fellowship at Mayo Clinic, Rochester, MN. His research interests include: a novel EEG (bispectral EEG: BSEEG) algorithm/device development for the detection of delirium and prediction of patient outcomes, epigenetic investigation of delirium pathophysiology and biomarker development, and development of novel therapeutics using a novel BSEEG mouse model of delirium. Before joining Stanford, he worked closely with Dr. Jimmy Potash, current chair of Hopkins Psychiatry, who mentored him for NIMH K23. He is currently conducting an epigenetic research study funded by NIMH R01 as well as a clinical study for a novel EEG device to screen delirium and predict patient outcomes. His invention of bispectral EEG (BSEEG) methods for the prediction of patient outcomes has been validated over 1,000 subjects with numerous peer-reviewed publications over the last several years. He received numerous awards including the 2018 Dlin/Fischer Clinical Research Award, the 2019 Visiting Professorship Award, as well as most recently 2023 Wayne Katon Research Award from the Academy of Consultation-Liaison Psychiatry for his innovative work on the development of a point-of-care EEG (BSEEG) method to screen delirium and predict patient outcomes.

Delirium screening has been largely dependent on instruments, such as Delirium Rating Scale (DRS) or Confusion Assessment Method (CAM). However, in a practical setting, those tools have not been consistently implemented. Although EEG has been well known to be useful in detecting delirium, its use is often practically limited for neurology specialists. Simplified EEG has been, however, used in different specialties to guide specific procedures. One is with anesthesia to monitor the depth of sedation. Another is with ECT to monitor seizure duration. We developed a novel BSEEG device and algorithm for delirium detection and outcome prediction. The BSEEG method has been validated in over 1,000 patients. The demo of the new thumb-size BSEEG device with the iPhone app will be introduced at the presentation.

Xiang Qian, MD, PhD, is a Pain Management Physician and Clinical Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford University. He is also the inaugural Stanford Medicine Endowed Director.

Dr. Qian is highly respected for his work on developing novel therapies for various chronic pain conditions, and he lectures internationally for those work and topics. Dr. Qian’s clinical interests include the treatment of acute and chronic pain, with special interest in migraine, headache, trigeminal neuralgia, glossopharyngeal neuralgia, hemifacial spasm, atypical facial pain, cancer pain, back pain, joint pain, nerve pain, and others. At Stanford, Dr. Qian developed many advanced surgical and interventional technologies for his patients, and he currently leads the CT-guided interventional pain program and is the recipient of Translational and Clinical Innovation Award at Stanford.

With his deep interest in clinical innovation and translational medicine, Dr. Qian is the faculty professor of Stanford Wearable Electronics Initiative (eWEAR) and has been working with colleagues from engineering school to develop mini implantable nerve stimulator, powered by wireless energy. Similar to a pacemaker for the heart, nerve stimulators are modulators for the nerves.

Due to his passion for global health and leadership experience, Dr. Qian was appointed as the Medical Director of Stanford International Medical Services (IMS) since 2016, where he has been working in collaboration with faculty members from all subspecialties and hospital administrations to help deliver care for international patients and promote international collaborations. His vision is to help Stanford become the leader in international medicine by providing its physicians and faculty the opportunities to expand their practice internationally and spread knowledge globally.

Dr. Qian completed his residency and fellowship training at Stanford. Prior to that, he received his PhD degree in Physiology and Biophysics from University of Miami Miller School of Medicine, and went through Postdoc fellowship training in Neuroscience at UCSF. Outside of the work he does at Stanford, Dr. Qian founded the Chinese American Physicians’ Society to foster his efforts in bringing medical knowledge internationally. Today, the society has more than 600 physician members from 50 states of the US, across over 38 different subspecialties.

In his free time, Dr. Qian enjoys reading, running, hiking and exploring the mountains and beaches of Northern California.

Coming Soon.

Ada received her Ph.D. degree from the EECS department at the University of California at Berkeley. Upon graduation, she spent some time in industries, working at Intel and SiBeam. Afterwards, she returned to academic and joined the faculty of the ECE department at the University of Illinois, Urbana-Champaign. Since then, she has changed her research direction from wireless communications to integrated biomedical systems. In 2008, she joined the faculty of the Department of Electrical Engineering at Stanford University. She is a Terman Fellow at Stanford University. She received the Okawa Foundation Research Grant in 2010 and NSF CAREER Award in 2013. She was a Chan Zuckerberg Biohub investigator.

Wireless passive sensors, being battery-free and simple, are suitable for disposable uses across various applications, from tracking food, monitoring the environment, to clinical diagnostics. However, their utilization is hampered by the complexity of existing readout techniques and the absence of memory functionality within the sensor. Here, we present a reader technique that can automatically lock to the sensor value wirelessly through inductive coupling, thus significantly reducing the reader complexity. By integrating a high-frequency audio link and wireless powering, we demonstrate a battery-free and flexible reader that paves the way for disposable solutions. We proceed to employ this reader for wireless temperature logging from a passive non-volatile thermistor sensor. This sensor logs temperature data based on the irreversible geometric change of low-melting-point metal during phase transitions, resulting in non-volatile resistance change. As a whole, these results establish the feasibility of a simplistic reader and a passive non-volatile thermistor sensor, opening up new possibilities for disposable and ubiquitous temperature monitoring, as well as a range of other applications.

David Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.

Can we expand our senses beyond the capacities that we come to the table with? To this end, our research feeds sensory signals to the brain through atypical sensory pathways. For example, we can address the limitations of deafness by turning auditory information into a series of vibrating patterns on the skin. This is done via the Neosensory wristband, which puts independently vibrating motors around the wrist. The wristband also reaches beyond hearing loss: we’re using it to feed in all kinds of information streams, from infrared to olfactory information to the stock market. Using this approach of sensory substitution, we can translate and feed almost any kind of data through the skin – thus expanding the human sensory experience.

Dr. Kapur is the Head of Digital Biomarkers at Verily Life Sciences, an Alphabet company focused on precision health. She is responsible for Verily’s precision measures strategy for smartphone and wearable sensor data and leads a team of over 80 scientists, engineers, and operations professionals. She manages a portfolio of R&D and commercial programs that use wearable and passive sensing technologies to better diagnose, monitor, and treat disease. 

Dr. Kapur is a Neuroscientist with over 15 years of experience in evidence generation, medical device development, neuromodulation, and signal processing. Her focus is on using traditional and machine learning methods to extract clinically relevant information from implanted and wearable sensors, building a base of evidence for their usefulness and validity, and making these technologies available to serve the needs of people living with disease. She is also a Visiting Full Professor by Special Appointment at the Radboud University Medical Center Department of Neurology.

Prior to joining Verily, Dr. Kapur was a Senior Clinical Research Scientist at NeuroPace, and part of the team that successfully completed a PMA for the world’s first brain-responsive neurostimulator for the treatment of epilepsy. Dr. Kapur received a Doctorate in Neuroscience from the University of California, San Francisco, where she specialized in signal processing and awake behaving electrophysiology. She also graduated from Stanford in 1998, with a degree in Human Biology.

Dr. Daniel Kraft is a Stanford & Harvard trained physician-scientist, entrepreneur & investor. He has served as faculty chair of medicine and neuroscience for Singularity University since its inception, and is chair of the XPRIZE Pandemic & Health Alliance.  

He is founder of NextMed Health, a program that explores accelerating technologies & the future of medicine and Digital.Health, a platform enabling discovery and use of digital medicine solutions. Daniel is a partner with Continuum Health Ventures funding early stage digital health & longevity startups.

Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & fellowships in hematology, oncology, & stem cell transplantation at Stanford.  He has published in Nature and Science through faculty positions at Stanford and UCSF. 

Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship & is member of the Kaufman Fellows Society. He has given 4TEDTalks. An avid pilot, he served as a flight surgeon in F-15 & F-16 squadrons and was a finalist for NASA Astronaut selection.

Paul is the Head of Smart Devices at Roche / Genentech. Paul has 20+ years of experience in medical device R&D, strategic marketing, product management, clinical research, and medical informatics.

Prior to Roche / Genentech, Paul was with Becton Dickinson(BD), as Worldwide Director of Strategic Marketing in their Pharmaceutical Systems business.

Paul was also the head of Product at WellDoc, Inc., where he led the product management activities for WellDoc’s portfolio of mobile health solutions. He was responsible for WellDoc’s landmark BlueStar™ product, a class II medical device and the world’s first reimbursed, prescription-only software for diabetes.

Paul’s prior experience includes 10 years in BD’s Diabetes Care business. Paul was responsible for the award-winning BD InterActiv® Diabetes Software, and was a member of the BD / Medtronic team that launched ParadigmLink®, the world’s first wireless blood glucose meter.

Paul holds four issued patents in medical software and drug delivery devices and has multiple patent applications. He is also an author of numerous peer-reviewed articles in medical informatics and diabetes. His education includes undergraduate studies in cognitive science and graduate work in health informatics and finance at the University of Minnesota and New York University.

Raymond Woo joined Ceribell in 2016 to lead its product research and development efforts. Throughout his career, Ray has worked to successfully bring innovative and disruptive medical device technologies to market. Prior to Ceribell, he was Global Head of Femtosecond Laser R&D at Abbott Medical Optics (now a part of J&J Vision), where he was responsible for R&D efforts across multiple product lines in both the laser cataract surgery and the laser vision correction markets. He helped to develop the Catalys laser cataract surgery system at Optimedica, which was acquired by Abbott Medical Optics. Ray received a Ph.D. and Master’s degree in Electrical Engineering from Stanford University, where his research focused on novel semiconductor devices. He has a Bachelor’s degree in Electrical Engineering and Computer Science from Duke University.

Dr. Nichole Young-Lin is a practicing board-certified obstetrician-gynecologist and the Women’s Health Clinical Lead at Google. Her work includes product development (Fitbit), AI research projects (including generative AI), and supporting women’s health efforts across Google’s platforms. She also currently serves on the board of the UNFPA West Africa Innovation Board. Her background is in global health, having co-founded an international maternal health nonprofit that works to empower providers in low-resource areas and worked as a technical advisor for digital health projects at the World Health Organization.

Dr. Young-Lin received her medical degree (MD) from the University of California, San Francisco (UCSF) and her masters in business administration (MBA) from Duke University’s Fuqua School of Business. She completed her residency training at Stanford University where she continues to serve as adjunct faculty.